CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- PositionProfit margin is 25.8%, higher than 95% of its Medical Instruments & Supplies peers (median 8.2%)
- FinancialsAltman Z-Score 13.28: safe zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
6.21%
Annual Rate
CNY 1.60Paid semi-annual
Payout Ratio
99.0%High
Payback Period
19.5 yr
Last Ex-Dividend
Jun 26, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.09BCNY310.89M · vs all stocks (USD)
Trailing P/E
25.23xvs Medical Instruments & Supplies peers
Revenue (TTM)
316.57MCNY47.08M · vs all stocks (USD)
Profit Margin
25.81%vs Medical Instruments & Supplies peers
Beta
0.2170xvs all stocks
52-Week Change
-40.69%vs all stocks
Forward Annual Dividend Yield
6.21%vs all stocks
Market Capitalization
2.09BCNY310.89M · vs all stocks (USD)
Enterprise Value
1.84BCNY273.74M · vs all stocks (USD)
Trailing P/E
25.23xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
6.53xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
3.56xvs Medical Instruments & Supplies peers
Enterprise to Revenue
5.82xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
22.94xvs Medical Instruments & Supplies peers
Gross Margin
64.13%vs Medical Instruments & Supplies peers
Profit Margin
25.81%vs Medical Instruments & Supplies peers
Operating Margin
10.51%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
6.33%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
14.23%vs Medical Instruments & Supplies peers
Revenue (TTM)
316.57MCNY47.08M · vs all stocks (USD)
Revenue per Share (TTM)
3.90CNYUpdated Aug 21, 2026Quarterly Revenue Growth
-15.40%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
205.42MCNY30.55M · vs all stocks (USD)
EBITDA (TTM)
71.61MCNY10.65M · vs all stocks (USD)
Net Income (TTM)
81.69MCNY12.15M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-26.50%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
56.94MCNY8.47M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-72.41MCNY-10.77M · vs all stocks (USD)
Forward Annual Dividend Rate
1.60CNYUpdated Aug 21, 2026Forward Annual Dividend Yield
6.21%vs all stocks
Trailing Annual Dividend Rate
1.30CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
5.05%vs all stocks
Payout Ratio
99.01%vs Medical Instruments & Supplies peers
Revenue
326.73MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
117.87MCNYFY2025 · Dec 31, 2025Gross Profit
208.86MCNYFY2025 · Dec 31, 2025Operating Income
75.63MCNY11.25M · vs all stocks (USD)
Pre-tax Income
95.17MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.98MCNYFY2025 · Dec 31, 2025Net Income
85.19MCNYFY2025 · Dec 31, 2025EBIT
95.64MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
101.34MCNYFY2025 · Dec 31, 2025Research & Development
51.30MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
36.08MCNYFY2025 · Dec 31, 2025Other Operating Expenses
3.54MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
103.38KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
473.45KCNYFY2025 · Dec 31, 2025EPS (Basic)
1.06CNYFY2025 · Dec 31, 2025EPS (Diluted)
1.05CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
80.36MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
80.36MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
85.19MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
46.36MCNYFY2025 · Dec 31, 2025Free Cash Flow
-43.91MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
98.78MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
85.19MCNYFY2025 · Dec 31, 2025Other Non-cash Items
-10.06MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-26.28MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-2.49MCNYFY2025 · Dec 31, 2025Capital Expenditures
-90.27MCNYFY2025 · Dec 31, 2025Purchase of Investments
-436.00MCNYFY2025 · Dec 31, 2025Sale of Investments
552.67MCNYFY2025 · Dec 31, 2025Other Investing Activity
-8.88MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
17.52MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
80.39MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-31.89MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-121.58MCNYFY2025 · Dec 31, 2025Other Financing Charges
12.38MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-60.70MCNYFY2025 · Dec 31, 2025Shares Outstanding
81.16MSharesUpdated Aug 21, 2026Float Shares
35.14MSharesUpdated Aug 21, 2026% Held by Insiders
56.46%vs all stocks
% Held by Institutions
0.79%vs all stocks
Total Cash (MRQ)
285.73MCNY42.49M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.55CNYUpdated Aug 21, 2026Total Debt (MRQ)
75.44MCNY11.22M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1308xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
3.54xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
7.16CNYUpdated Aug 21, 2026Total Assets
672.93MCNY100.07M · vs all stocks (USD)
Total Current Assets
376.92MCNYFY2025 · Dec 31, 2025Total Liabilities
107.37MCNYFY2025 · Dec 31, 2025Total Non-current Assets
296.01MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
19.74MCNYFY2025 · Dec 31, 2025Total Current Liabilities
87.63MCNYFY2025 · Dec 31, 2025Cash
98.78MCNYFY2025 · Dec 31, 2025Cash Equivalents
24.06MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
122.84MCNYFY2025 · Dec 31, 2025Other Short-term Investments
171.16MCNYFY2025 · Dec 31, 2025Accounts Receivable
42.25MCNYFY2025 · Dec 31, 2025Inventory
34.07MCNYFY2025 · Dec 31, 2025Accounts Payable
9.67MCNYFY2025 · Dec 31, 2025Short-term Debt
35.46MCNYFY2025 · Dec 31, 2025Other Current Liabilities
634.05KCNYFY2025 · Dec 31, 2025Long-term Debt
15.00MCNYFY2025 · Dec 31, 2025Common Stock (Book)
81.16MCNYFY2025 · Dec 31, 2025Retained Earnings
61.66MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
565.55MCNY84.10M · vs all stocks (USD)
Treasury Stock
15.60MCNYFY2025 · Dec 31, 202552-Week Low
21.11CNYUpdated Aug 21, 202652-Week High
68.00CNYUpdated Aug 21, 202652-Week Change
-40.69%vs all stocks
Beta
0.2170xvs all stocks
50-Day MA
25.18CNYUpdated Aug 21, 2026200-Day MA
38.03CNYUpdated Aug 21, 2026Avg 10-Day Volume
1.17MSharesUpdated Aug 21, 2026Avg 30-Day Volume
1.34MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
1.01CNYUpdated Aug 21, 20263 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
How is this stock valued?
Price Below Mean With Profitability And Equity
Price sits well below its yearly mean, profitable three years, and its equity ratio is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Profit margin is 25.8%, higher than 95% of its Medical Instruments & Supplies peers (median 8.2%)Significant
Profit margin: 0.26Industry median: 0.08Industry P95: 0.25Peers compared: 65.00
Financial Health
Altman Z-Score 13.28: safe zoneNotable
Altman Z-Score: 13.28
High earnings qualityNotable
Earnings Quality Score: 0.51
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Kung Long Batteries Industrial Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Wonik Materials Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Myoung Shin Industrial Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Norsyn Crop Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Guangdong Tianhe Agricultural Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
A&D Holon Holdings Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Gulf Marine Services PLC
Tier 1ProductionThroughput-Bound ConversionFlowRule
National Company for Glass Industries
Tier 1ProductionThroughput-Bound ConversionFlowRule
Giken Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Beijing Hanjian Heshan Pipe Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Jiangxi Xinyu Guoke Technology Technology Co., Ltd.
3 interpretationsMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And Equity
Wuxi Quechen Silicon Chemical Co., Ltd.
3 interpretationsMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And Equity
Beijing InHand Networks Technology Co., Ltd.
3 interpretationsMulti-Year Revenue, Profit, And Income GrowthIndustry-Benchmarked ROA and Margin ElevatedPrice Below Mean With Profitability And Equity